STARCEL™ Silicified Microcrystalline Cellulose (SMCC) is a high quality co-processed pharmaceutical excipient, developed by NB Entrepreneurs, for enhanced flow, compressibility and direct compression properties in tablet formulations.
STARCEL™ is manufactured from high quality Microcrystalline Cellulose (MCC) and Colloidal Silicon Dioxide, which aids the pharmaceutical and nutraceutical industry by providing improved tablet consistency, production efficiency and reliability in high-speed tableting operations.
Silicified Microcrystalline Cellulose (SMCC) is an advanced pharmaceutical excipient, which is prepared through mixing Microcrystalline Cellulose (MCC) with Colloidal Silicon Dioxide.
It is a co-processed excipient with the same binding and compression characteristics as conventional MCC. Moreover, it provides better Powder Flow and Compactibility. The suitability of Silicified MCC for direct compression tablet manufacturing is due to these properties.
Microcrystalline Cellulose (MCC)
Primary excipient
+
Colloidal Silicon Dioxide
Flow enhancer
=
STARCEL™ SMCC
Co-processed Excipient
Silicified Microcrystalline Cellulose is chosen by pharmaceutical manufacturers as it improves formulation performance and efficiency in manufacturing as compared to conventional MCC.
NB Entrepreneurs is a reliable and trusted pharmaceutical manufacturer providing high-quality excipients to nutraceutical and pharmaceutical firms all over the world.
Consistent product quality with superior powder flow for uniform die filling.
Outstanding compaction properties with reliable batch-to-batch performance.
Regulatory-compliant manufacturing resulting in tablets of higher crush strength.
Consistent volumetric fill with reduced tablet weight variation across batches.
Improved API distribution ensuring precise dosage and content consistency.
Lower sticking and capping risk, suitable for demanding direct compression.
Optimised specifically for direct compression tablet manufacturing processes.
Excellent performance on modern rotary tablet presses at maximum throughput.
Adding Colloidal Silicon Dioxide enhances compatibility and particle flow, helping manufacturers achieve better tablet production consistency.
| Property | Conventional MCC | ⭐ STARCEL™ Silicified MCC |
|---|---|---|
| Composition | Microcrystalline Cellulose | MCC + Colloidal Silicon Dioxide |
| Flowability | Good | ✦ Excellent |
| Compressibility | Good | ✦ Superior |
| Tablet Hardness | Standard | ✦ Enhanced |
| Die Filling | Good | ✦ Better |
| Direct Compression | Suitable | ✦ Optimized |
| High-Speed Tableting | Moderate | ✦ Excellent |
| Manufacturing Efficiency | Good | ✦ Improved |
Direct compression tablet method reduces processing steps, production costs and manufacturing costs. STARCEL™ supports direct compression by:
Direct compression tablet formulations
Vitamin and mineral supplements
Botanical and Ayurvedic tablets
Consumer healthcare tablets
Large-scale tablet production
NB Entrepreneurs is a reliable and trusted pharmaceutical manufacturer providing high-quality excipients to nutraceutical and pharmaceutical firms all over the world.
STARCEL™ is manufactured using stringent quality systems and pharmaceutical-grade manufacturing practices.
Standardized testing across every production run.
Multi-stage QC from raw material to product.
Testing per USP and internal analytical methods.
Full traceability for regulatory submissions.
| Parameter | Specification | Standard |
|---|---|---|
| STARCEL™ SMCC — USP-NF Specifications | ||
| Description | White or almost white, free-flowing powder | Visual |
| Identification | Complies — MCC & Silicon Dioxide | USP/NF |
| pH (2% suspension) | 5.0 – 7.5 | USP <791> |
| Loss on Drying | NMT 7.0% | USP <731> |
| Residue on Ignition | NMT 0.3% | USP <281> |
| Heavy Metals | NMT 0.001% | USP <231> |
| Silicon Dioxide Content | 1.5 – 3.5% (w/w) | ICP/USP |
| Water-Soluble Substances | NMT 0.25% | USP/NF |
| Starch | Absent | USP/NF |
| Microbial Limits | Complies with USP/NF | USP <61>/<62> |
| Grade | Application |
|---|---|
| SMCC 90 | Direct Compression Tablet Formulations |
| SMCC 90 LM | Enhanced Flow & Lubrication-Sensitive Formulations |
| Packaging Type | Available Size |
|---|---|
| HDPE Bags | 20 kg, 25 kg |
| Paper Bags | 20 kg, 25 kg |
| FIBC | 400 kg |
| Container Type | Palletized | Non-Palletized |
|---|---|---|
| 20 Ft Container | 10,000 kg | 12,000 kg |
| 40 Ft Container | 20,000 kg | 24,000 kg |
* Custom packaging available upon request.
Silicified Microcrystalline Cellulose is a co-processed excipient made of MCC and Colloidal Silicon Dioxide which increases the flowability and compressibility.
It has wide application in the manufacturing of direct compression tablet, nutraceutical tablets, herbal formulation and high-speed tablet production.
In comparison to conventional MCC, Silicified MCC is typically more flowable, more compressible and more efficient to manufacture.
STARCEL™ offers enhanced flowability, excellent compactibility, superior tablet hardness and increased production consistency.
Yes. STARCEL™ is specially formulated for direct compression tablet production.
Pharmaceutical, nutraceutical, herbal, and OTC product manufacturers use STARCEL™.
Yes. STARCEL™ is produced under the applicable USP quality standards.
There are currently two available grades: SMCC 90 and SMCC 90 LM.
Yes. It has improved compressibility that results in tablets of higher crush strength and lower friability.
Yes. It is generally employed in nutraceutical and dietary supplements.
Collaborate with NB Entrepreneurs for high-quality STARCEL™ Silicified Microcrystalline Cellulose that is engineered to meet high-performance direct compression, tablet performance and global pharmaceutical manufacturing standards.